--- title: "OneMedNet | 10-Q: FY2026 Q1 Revenue: USD 96 K" type: "News" locale: "en" url: "https://longbridge.com/en/news/286610722.md" datetime: "2026-05-15T20:29:19.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286610722.md) - [en](https://longbridge.com/en/news/286610722.md) - [zh-HK](https://longbridge.com/zh-HK/news/286610722.md) --- # OneMedNet | 10-Q: FY2026 Q1 Revenue: USD 96 K Revenue: As of FY2026 Q1, the actual value is USD 96 K. EPS: As of FY2026 Q1, the actual value is USD -0.04. EBIT: As of FY2026 Q1, the actual value is USD -2.542 M. OneMedNet Corporation operates as a single segment, focusing on digital medical image management, exchange, and sharing solutions . #### Revenue by Product Offering - Subscription revenue (BEAM) decreased by -100% to $0 thousand for the three months ended March 31, 2026, from $58 thousand in the prior year period, due to the platform’s decommissioning in May 2025 . - Web imaging revenue (Real-World Data) increased by 22% to $96 thousand for the three months ended March 31, 2026, from $79 thousand in the prior year period, driven by growth in the customer base and higher data delivery volume . - Total Revenue decreased by -30% to $96 thousand for the three months ended March 31, 2026, from $137 thousand in the prior year period . #### Revenue by Geographic Region - Americas revenue was $91 thousand for the three months ended March 31, 2026, compared to $119 thousand for the same period in 2025 . - Rest of World revenue was $5 thousand for the three months ended March 31, 2026, compared to $18 thousand for the same period in 2025 . - Total revenue was $96 thousand for the three months ended March 31, 2026, compared to $137 thousand for the same period in 2025 . #### Operational Metrics - Cost of Revenue increased by 32% to $476 thousand for the three months ended March 31, 2026, from $361 thousand in the prior year, primarily due to increased data and curation charges . - Gross Margin was - $380 thousand for the three months ended March 31, 2026, compared to - $224 thousand in the prior year, representing a 70% increase in loss . - General and Administrative Expenses increased by 9% to $1,483 thousand for the three months ended March 31, 2026, from $1,362 thousand in the prior year, mainly due to increased share-based compensation expense . - Sales and Marketing Expenses increased by 30% to $378 thousand for the three months ended March 31, 2026, from $290 thousand in the prior year, driven by increased headcount for iRWD sales growth . - Research and Development Expenses decreased by -11% to $311 thousand for the three months ended March 31, 2026, from $348 thousand in the prior year . - Total Operating Expenses increased by 9% to $2,172 thousand for the three months ended March 31, 2026, from $2,000 thousand in the prior year . - Loss from Operations was - $2,552 thousand for the three months ended March 31, 2026, compared to - $2,224 thousand in the prior year, an increase in loss of 15% . - Net Loss increased by 29% to - $2,453 thousand for the three months ended March 31, 2026, from - $1,902 thousand in the prior year . #### Cash Flow - Net Cash Used in Operating Activities was - $1,542 thousand for the three months ended March 31, 2026, compared to - $1,854 thousand in the prior year . - Net Cash Provided by Investing Activities was $352 thousand for the three months ended March 31, 2026, compared to $1,920 thousand in the prior year . - Net Cash Provided by (Used in) Financing Activities was $838 thousand for the three months ended March 31, 2026, compared to - $94 thousand in the prior year . #### Unique Financial Metrics - Change in Fair Value of Crypto Assets – Bitcoin was - $102 thousand for the three months ended March 31, 2026, compared to $662 thousand in the prior year . - Realized Loss (Gain) on Sale of Crypto Assets – Bitcoin was $188 thousand for the three months ended March 31, 2026, compared to - $531 thousand in the prior year . - Change in Fair Value of SEPA Derivative Liabilities was - $179 thousand for the three months ended March 31, 2026, compared to - $324 thousand in the prior year . #### Future Outlook and Strategy OneMedNet Corporation faces substantial doubt about its ability to continue as a going concern due to recurring net losses and insufficient cash for operations . The company plans to raise additional capital through equity or debt offerings and aims for profitable operations, while also addressing a Nasdaq non-compliance notice . Strategically, the company transitioned from its legacy BEAM platform in May 2025 to focus on a unified real-world data platform, which has driven growth in data deliveries . ### Related Stocks - [ONMD.US](https://longbridge.com/en/quote/ONMD.US.md) ## Related News & Research - [Endo GUC Trust Provides Its First Quarter 2026 Report](https://longbridge.com/en/news/286622222.md) - [Bureau Veritas: All resolutions passed at May 19, 2026 Shareholders' Meeting.](https://longbridge.com/en/news/286946080.md) - [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md) - [FRONTERA ANNOUNCES FIRST QUARTER 2026 RESULTS | FECCF Stock News](https://longbridge.com/en/news/286507909.md) - [The Home Depot Announces First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance | HD Stock News](https://longbridge.com/en/news/286890512.md)